What is ANGO's health score?

ANGIODYNAMICS INC (ANGO) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ANGO's estimated fair value?

Based on our 5-year discounted cash flow model, ANGIODYNAMICS INC's estimated fair value is $15.46 per share, representing a 6.9% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ANGO undervalued or overvalued?

Our model currently rates ANGO as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

Create an account for unlimited access

ANGIODYNAMICS INC (ANGO)

Healthcare Fair Value low weak

$14.47

Updated: 2026-07-16

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

38 Weak

Relative Value

40 Weak

Capital Allocation

50 Mixed

Risk Management

70 Healthy

Est. Fair Value $15.46

DCF Upside +6.9%

Sector Rank #2149 of 12118

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

Industry Related Stocks

Adagio Medical Holdings, Inc. (ADGM) ADM TRONICS UNLIMITED, INC. (ADMT) AETHLON MEDICAL INC (AEMD) Axe Compute Inc. (AGPU) ALIGN TECHNOLOGY INC (ALGN) ALLURION TECHNOLOGIES, INC. (ALUR)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.